These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16520718)

  • 1. Inhibitory effect of C-reactive protein on the release of tissue factor pathway inhibitor from human endothelial cells: reversal by low molecular weight heparin.
    Mousa SA
    Int Angiol; 2006 Mar; 25(1):10-3. PubMed ID: 16520718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of endothelial cell tube formation by the low molecular weight heparin, tinzaparin, is mediated by tissue factor pathway inhibitor.
    Mousa SA; Mohamed S
    Thromb Haemost; 2004 Sep; 92(3):627-33. PubMed ID: 15351861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of unfractionated heparin and low molecular weight heparin on vascular endothelial cell tissue factor pathway inhibitor release: a model for assessing intrinsic thromboresistance.
    Li Y; Rodriquez M; Spencer FA; Becker RC
    J Thromb Thrombolysis; 2002 Oct; 14(2):123-9. PubMed ID: 12714831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin stimulates release of tissue factor pathway inhibitor from the vascular endothelium.
    Kostovski E; Dahm AE; Iversen N; Hjeltnes N; Østerud B; Sandset PM; Iversen PO
    Blood Coagul Fibrinolysis; 2011 Jun; 22(4):254-9. PubMed ID: 21297449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic properties of the low molecular weight heparin, tinzaparin: effect of molecular weight distribution on plasma tissue factor pathway inhibitor in healthy human subjects.
    Mousa SA; Bozarth J; Barrett JS
    J Clin Pharmacol; 2003 Jul; 43(7):727-34. PubMed ID: 12856386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin/low molecular weight heparin and tissue factor pathway inhibitor.
    Abildgaard U
    Haemostasis; 1993 Mar; 23 Suppl 1():103-6. PubMed ID: 8388347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bemiparin and fluid flow modulate the expression, activity and release of tissue factor pathway inhibitor in human endothelial cells in vitro.
    Westmuckett AD; Kakkar VV; Hamuro T; Lupu F; Lupu C
    Thromb Haemost; 2001 Dec; 86(6):1547-54. PubMed ID: 11776326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of unfractionated heparin, low molecular weight heparin and both combined for releasing total and free tissue factor pathway inhibitor.
    Altman R; Scazziota A; Rouvier J
    Haemostasis; 1998; 28(5):229-35. PubMed ID: 10420071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparin.
    Mousa SA; Linhardt R; Francis JL; Amirkhosravi A
    Thromb Haemost; 2006 Dec; 96(6):816-21. PubMed ID: 17139378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further insight into the heparin-releasable and glycosylphosphatidylinositol-lipid--anchored forms of tissue factor pathway inhibitor.
    Ellery PE; Hardy K; Oostryck R; Adams MJ
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):267-78. PubMed ID: 18160611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of protamine sulphate on plasma tissue factor pathway inhibitor released by intravenous and subcutaneous unfractionated and low molecular weight heparin in man.
    Holst J; Lindblad B; Bergqvist D; Hedner U; Nordfang O; Ostergaard P
    Thromb Res; 1997 May; 86(4):343-8. PubMed ID: 9187023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of unfractionated heparin and low molecular weight heparin on intravascular tissue factor pathway inhibitor: evidence for a difference in antithrombotic action.
    Hansen JB; Sandset PM; Huseby KR; Huseby NE; Bendz B; Ostergaard P; Nordøy A
    Br J Haematol; 1998 Jun; 101(4):638-46. PubMed ID: 9674734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin induces synthesis and secretion of tissue factor pathway inhibitor from endothelial cells in vitro.
    Hansen JB; Svensson B; Olsen R; Ezban M; Osterud B; Paulssen RH
    Thromb Haemost; 2000 Jun; 83(6):937-43. PubMed ID: 10896252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-angiogenic mechanisms and efficacy of the low molecular weight heparin, tinzaparin: anti-cancer efficacy.
    Mousa SA; Mohamed S
    Oncol Rep; 2004 Oct; 12(4):683-8. PubMed ID: 15375485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TFPI antigen levels in normal human volunteers after intravenous and subcutaneous administration of unfractionated heparin and a low molecular weight heparin.
    Hoppensteadt DA; Walenga JM; Fasanella A; Jeske W; Fareed J
    Thromb Res; 1995 Jan; 77(2):175-85. PubMed ID: 7740509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravascular release and urinary excretion of tissue factor pathway inhibitor during heparin treatment.
    Brodin E; Svensson B; Paulssen RH; Nordoy A; Hansen JB
    J Lab Clin Med; 2004 Nov; 144(5):246-53; discussion 226-7. PubMed ID: 15570242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfated non-anticoagulant low molecular weight heparin in the prevention of cancer and non-cancer associated thrombosis without compromising hemostasis.
    Darwish NHE; Godugu K; Mousa SA
    Thromb Res; 2021 Apr; 200():109-114. PubMed ID: 33582600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fucoidan, as heparin, induces tissue factor pathway inhibitor release from cultured human endothelial cells.
    Giraux JL; Tapon-Bretaudière J; Matou S; Fischer AM
    Thromb Haemost; 1998 Oct; 80(4):692-5. PubMed ID: 9798992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic effects of low molecular weight heparin in obese subjects following subcutaneous administration of 75 IU/kg on plasma tissue factor pathway inhibitor and nitric oxide.
    Mousa SA; Johansen K
    Int Angiol; 2005 Mar; 24(1):40-2. PubMed ID: 15876997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular effects of heparin on the production and release of tissue factor pathway inhibitor in human endothelial cells in culture.
    Lupu C; Poulsen E; Roquefeuil S; Westmuckett AD; Kakkar VV; Lupu F
    Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2251-62. PubMed ID: 10479670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.